Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Marketing Authorisations (MA) containing MolPort-001-783-406 in Europe. Original Data : EMA Website

Client Email

Product

MolPort-001-783-406
Europe

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

MolPort-001-783-406

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 10 USDMF, 7 CEP/COS, 1 JDMF, 6 EU WC, 3 KDMF, 7 NDC API, 11 Listed Suppliers, $ API Reference Price

21 API Suppliers
10 USDMF
7 CEP/COS
1 JDMF
6 EU WC
3 KDMF
7 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 17 FDA Orange Book, 6 Europe, 3 Canada, 1 Australia, 5 South Africa, 8 Listed Dossiers

40 FDF Dossiers
17 FDA Orange Book
6 Europe
3 Canada
1 Australia
5 South Africa
8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 6MG/ML, TABLET;ORAL - 2MG

INJECTABLE;INJECTION - 6MG/ML
TABLET;ORAL - 2MG

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 2 Seqens, 2 DKSH, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 DFE Pharma, 1 Finar, 3 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 19 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 7 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 8 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 28 Fillers, Diluents & Binders, 21 Controlled & Modified Release, 12 Direct Compression, 9 Thickeners and Stabilizers, 9 Film Formers & Plasticizers, 8 Topical, 8 Lubricants & Glidants, 8 Co-Processed Excipients, 5 Granulation, 5 Taste Masking, 5 Solubilizers, 5 Empty Capsules, 5 Disintegrants & Superdisintegrants, 4 Coloring Agents, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 3 API Stability Enhancers, 3 Parenteral, 2 Emulsifying Agents, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents

43 Coating Systems & Additives
28 Fillers, Diluents & Binders
21 Controlled & Modified Release
12 Direct Compression
9 Thickeners and Stabilizers
9 Film Formers & Plasticizers
8 Topical
8 Lubricants & Glidants
8 Co-Processed Excipients
5 Granulation
5 Taste Masking
5 Solubilizers
5 Empty Capsules
5 Disintegrants & Superdisintegrants
4 Coloring Agents
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
3 API Stability Enhancers
3 Parenteral
2 Emulsifying Agents
2 Rheology Modifiers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 20 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices

1 US Medicaid Prescriptions
3 Finished Drug Prices

MARKET PLACE

2 APIs, 4 FDF Dossiers

2 APIs
4 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

$ API Ref.Price (USD/KG) : 106,772 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 1Aspen Pharma Trading Limited,

02 1Fresenius Kabi Oncology Plc

03 1PIERRE FABRE MEDICAMENT

04 1Pierre Fabre Medicament

05 1Pierre Fabre Medicament Production

06 1The Fresenius Kabi Oncology Plc

filter Active Ingredients Reset all filters

6 All

01 3Busulfan

02 3busulfan

filter Dosage Form Reset all filters

6 All

01 1Busulfano 60Mg 8 Joined The Parenteral Use

02 2CONCENTRATE FOR SOLUTION FOR INFUSION

03 2Concentrate to the infusion fluid, resolution

04 1FILMDRAGERAD TABLETT

filter Country Reset all filters

6 All

01 1Italy

02 2Norway

03 3Sweden

filter Brand Name Reset all filters

6 All

01 3Busilvex

02 2Busulfan Fresenius Kabi

03 1Myleran

FDF Dossiers
FDA Orange Book
Europe
Canada
Australia
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

Aspen Pharma Trading Limited,

TIDES Europe 2024

Aspen API. More than just an API.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Sweden

Brand Name : Myleran

Dosage Form : FILMDRAGERAD TABLETT

Dosage Strength : 2 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Aspen API Comapny Banner

Product Web Link

Digital Content

02

Fresenius Kabi Oncology Plc

AAPS 2024

Not Confirmed

Fresenius Kabi Oncology Plc

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

Brand Name : Busulfan Fresenius Kabi

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 6 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

The Fresenius Kabi Oncology Plc

AAPS 2024

Not Confirmed

The Fresenius Kabi Oncology Plc

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Norway

Brand Name : Busulfan Fresenius Kabi

Dosage Form : Concentrate to the infusion fluid, resolution

Dosage Strength : 6 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pierre Fabre Medicament

AAPS 2024

Not Confirmed

Pierre Fabre Medicament

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

Brand Name : Busilvex

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 6 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

05

PIERRE FABRE MEDICAMENT

AAPS 2024

Not Confirmed

PIERRE FABRE MEDICAMENT

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Busilvex

Dosage Form : Busulfano 60Mg 8 Joined The Parenteral Use

Dosage Strength : 8 VIALS EV 10 ml 6 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

06

Pierre Fabre Medicament Production

AAPS 2024

Not Confirmed

Pierre Fabre Medicament Production

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Norway

Brand Name : Busilvex

Dosage Form : Concentrate to the infusion fluid, resolution

Dosage Strength : 6 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?